TIMOTHY H. KRATZ
Partner
Timothy is a veteran complex trial lawyer, with over 35 years of first-chair courtroom experience. He leads or has led litigation teams in numerous large, complex matters, including cases in the fields of patents and other forms of intellectual property, technology licenses and development, trade and competition, healthcare, securities, professional malpractice and all aspects of business litigation. For the past 16 years, he has built and led teams focused on Hatch-Waxman litigation, serving as lead counsel in all phases of numerous ANDA cases for leading generic pharmaceutical companies. He has significant experience in this field, including serving as lead counsel on more than 100 ANDA applications with Paragraph IV challenges.
Timothy is a recognized international speaker on topical issues pertinent to the life sciences industry and patent litigation, having presented at industry conferences throughout the United States, and in South Korea and on numerous occasions in India. He has been tendered and qualified as an expert in an international litigation matter in the field of U.S. patent litigation procedures. He was also his prior firm’s chair of the life sciences industry team, serving in this firm management position for more than two years. As such, he has coordinated multi-disciplinary and multi-office teams of lawyers serving the life sciences industry.
Timothy has a depth of experience in the management of high stakes, high profile commercial litigation. He has tried many cases to verdict in a variety of jurisdictions, and argued several appeals before federal and state appellate courts and in fact has been selected on multiple occasions from joint-defense group counsel to argue an appeal on behalf of multiple leading companies in the field. He has also taught trial advocacy skills to both law students and lawyers in several states. He has been a member of the Georgia bar since 1989.
PUBLIC PRESENTATIONS
Speaker, “Biosimilars: The Way Forward,” World IP Forum 2017, Bangalore, India, April 28, 2017
Speaker, “Managing Costs of Litigation through Use of Alternative Fee Arrangements,” In House Counsel Forum (IHCF) Winter Academy, Seoul, South Korea, December, 2016
Speaker, “Patent Prosecution and Litigation Issues,” 8 th Annual
Pharmaceutical and Medical Device Conference, Chicago, November 10, 2016Speaker, “U.S. Supreme Court 2014 – Impact on Patent Litigation Strategies,” 7 th Global Intellectual Property Convention, Mumbai, India, January 17, 2015
Speaker, “New Challenges in U.S. Pharmaceutical Patent Litigation,” World IP Forum, New Delhi, India, January 11, 2015
Speaker, “Understanding Cross Border Infringement and Its Effect on Intellectual Property,” 8th Annual International Intellectual Property Summit, Ahmedabad, India, January 9, 2015Speaker, “Exploring Strategies for Biosimilar Development in the United States; Regulatory, IP & Commercial Considerations Gleaned from the Global Framework,” Legal and Regulatory Summit on Generic Drugs, American Conference Institute, New York City, July 25, 2014
Speaker, “Latest Developments in Patent Litigation,” In House Counsel Forum (IHCF) Spring Academy, Seoul, South Korea, April, 2014
Moderator, “New Challenges in Managing IP Litigation,” 5th Annual Medical Device and Life Sciences Conference: Innovation, Investing and Regulatory Issues, Chicago, November 7, 2013
Panelist, "ANDA Litigation and Biosimilars", International IP Skills Summit, September 7 and 8, 2017, Bangalore India.
Speaker, “Pharma and the Patent System”, Global IP Conference, January 23, 2018, Bangalore, India
Moderator, “Challenges and Countermeasures in Intellectual Property Litigation”, Global IP Conference, January 24, 2018, Bangalore, India
Speaker, “Patent Law Suit Risk Assessment”, IP Skills Summit, June 27, 2018, Hyderabad, India
Speaker, “A Strategic View of 505(b)(2) ANDAs”, Global IP Conference, January 18, 2019, Bangalore, India
Speaker, “Paragraph IV Litigation Trends, Analysis and Future Predictions”, IP Skills Summit, August 14, 2019, Hyderabad, India
Moderator, “Generics to Complex Generics to Super Generics – The Reality and Way Forward”, Global IP Conference, January 10, 2020, New Delhi, India
